Clinical Trial: An Observational Study to Learn More About How Well a Treatment Works When Given After Treatment With Atezolizumab and Bevacizumab or Another Similar Combination of Drugs in Adults With Liver Cancer That Cannot be Treated With Surgery
Study Status: Completed
Recruit Status: RECRUITING
Condition: Unresectable Hepatocellular Carcinoma
Study Type: OBSERVATIONAL
Official Title: An Observational Study in Patients With Unresectable Hepatocellular Carcinoma (uHCC) Following Treatment With Atezolizumab Plus Bevacizumab (AB) or With Another Approved Immuno-oncology Immune Checkpo
Brief Summary:
This is an observational study in which only data will be collected from adults with unresectable hepatocellular carcinoma.These adults should be prescribed a different treatment after treatment with atezolizumab and bevacizumab, or another similar combination of drugs, by their doctors.Unresectable hepatocellular carcinoma (uHCC) is a type of liver cancer that cannot be treated with surgery.In the past, sorafenib was the only approved first-line anti-cancer drug for people with uHCC.Regorafenib and other drugs…
Read more